A Multicenter, Open-Label, Randomized, Pilot-Study to Evaluate the Efficacy and Safety of the Combination of Etanercept (ETN) and Methotrexate and of Etanercept (ETN) Alone in Patients With Plaque Psoriasis Despite Methotrexate Therapy.

Trial Profile

A Multicenter, Open-Label, Randomized, Pilot-Study to Evaluate the Efficacy and Safety of the Combination of Etanercept (ETN) and Methotrexate and of Etanercept (ETN) Alone in Patients With Plaque Psoriasis Despite Methotrexate Therapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Etanercept; Methotrexate
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 29 Sep 2009 Actual end date (1 Dec 2006) added as reported by ClinicalTrials.gov.
    • 29 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top